COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,436 Articles (22,835 medRxiv, 8,601 bioRxiv)

Most recent first Previous |  Page 1330: Articles 13291-13300  | Next

Use of health care services during the Covid-19 pandemic in Ethiopia: Evidence from a health facility survey
Shuka, Z. S., Mebratie, A. D., Alemu, G., Rieger, M., Bedi, A. S.
10.1101/2021.08.09.21261754 — Posted: 2021-08-10
Progress of the Delta variant and erosion of vaccine effectiveness, a warning from Utah
Keegan, L., Truelove, S. A., Lessler, J.
10.1101/2021.08.09.21261554 — Posted: 2021-08-10
Evaluation of the Liberty16 mobile real time PCR device for use with the SalivaDirect assay for SARS-CoV-2 testing
Yolda-Carr, D., Thammavongsa, D. A., Vega, N., Turner, S. J., Pickering, P. J., Wyllie, A. L.
10.1101/2021.08.08.21261746 — Posted: 2021-08-10
Antibody response in individuals affected with Sars-Cov-2 infection: temporal trends and qualitative and quantitative differences in symptomatic and asymptomatic subjects. A Cross Sectional Analysis. Ab-Covid Study
Abraha, I., Germani, A., Pasquarelli, E., Pascolini, S., Antonietti, R., Argenti, S., Fioravanti, A., Martini, E., Aristei, L., Mancinelli, P., Ottaviani, M. L., Roselli, M., Barzacca, M., Belardinelli, E., Micheli, M.
10.1101/2021.08.09.21261450 — Posted: 2021-08-10
Diagnosing COVID-19 in human serum using Raman spectroscopy: a preliminary study
Goulart, A. C. C., Silveira, L., Carvalho, H. C., Dorta, C. B., Pacheco, M. T. T., Zangaro, R. A.
10.1101/2021.08.09.21261798 — Posted: 2021-08-10
Reducing false reassurance following negative results from asymptomatic coronavirus (Covid-19) testing: an online experiment
Batteux, E., Bonfield, S., Jones, L. F., Carter, H., Gold, N., Amlot, R., Marteau, T. M., Weston, D.
10.1101/2021.08.03.21261482 — Posted: 2021-08-10
The effect of eye protection on SARS-CoV-2 transmission: a systematic review
Byambasuren, O., Beller, E., Clark, J., Collignon, P., Glasziou, P.
10.1101/2021.08.08.21261770 — Posted: 2021-08-09
A Systematic Comparison of Differential Analysis Methods for CyTOF Data
Arend, L., Bernett, J., Manz, Q., Klug, M., Lazareva, O., Baumbach, J., Bongiovanni, D., List, M.
10.1101/2021.08.09.455609 — Posted: 2021-08-09
A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concern
Wagner, T. R., Schnepf, D., Beer, J., Klingel, K., Ruetalo, N., Kaiser, P. D., Junker, D., Sauter, M., Traenkle, B., Frecot, D. I., Becker, M., Schneiderhan-Marra, N., Ohnemus, A., Schwemmle, M., Schindler, M., Rothbauer, U.
10.1101/2021.08.08.455562 — Posted: 2021-08-09
A Tethered Ligand Assay to Probe SARS-CoV-2:ACE2 Interactions
Bauer, M. S., Gruber, S., Hausch, A., Milles, L. F., Nicolaus, T., Schendel, L. C., Lopez Navajas, P., Procko, E., Lietha, D., Bernardi, R. C., Gaub, H. E., Lipfert, J.
10.1101/2021.08.08.455468 — Posted: 2021-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).